Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SMMT

Summit Therapeutics Inc

Jun 18 • 04:00PM ET

13.75

-0.32 -2.27 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: EXEL MRNA REGN VRTX BMRN INCY IONS ALNY GILD AMGN

| Held by: XBI VTI VB VXF VBR IBB IWP VHT IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.60	Insider Own	83.15%	Shs Outstand	776.02M	Perf Week	5.12%
Market Cap	10.67B	Forward P/E	-	EPS next Y	-1.10	Insider Trans	1.23%	Shs Float	130.76M	Perf Month	-13.25%
Enterprise Value	10.09B	PEG	-	EPS next Q	-0.27	Inst Own	15.52%	Short Float	27.63%	Perf Quarter	-12.53%
Income	-1.21B	P/S	-	EPS this Y	24.45%	Inst Trans	1.27%	Short Ratio	7.46	Perf Half Y	-20.20%
Sales	0.00M	P/B	19.55	EPS next Y	-1.34%	ROA	-233.81%	Short Interest	36.13M	Perf YTD	-21.38%
Book/sh	0.70	P/C	17.82	EPS next 5Y	30.13%	ROE	-270.95%	52W High	30.98 -55.62%	Perf Year	-31.80%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	-52.45% -13.76%	ROIC	-214.31%	52W Low	12.55 9.56%	Perf 3Y	561.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.44% 7.11%	Perf 5Y	108.02%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-384.68%	Oper. Margin	-	ATR (14)	1.10	Perf 10Y	69.97%
Dividend Ex-Date	-	Quick Ratio	7.41	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.16	Recom	1.69
Dividend Gr. 3/5Y	- -	Current Ratio	7.41	EPS Q/Q	-186.74%	SMA20	-9.25%	Beta	-1.23	Target Price	29.69
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	-24.00%	Rel Volume	1.80	Prev Close	14.07
Employees	265	LT Debt/Eq	0.03	Earnings	Apr 30 AMC	SMA200	-23.44%	Avg Volume	4.84M	Price	13.75
IPO	Mar 05, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.85% -100.00%	Trades		Volume	8,702,671	Change	-2.27%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)